There are 2789 resources available
131P - Impact of body mass (BMI) and weight change after adjuvant treatment in patients (pts) with HER2-positive early breast cancer
Presenter: Maria Alice Franzoi
Session: ePoster Display
132P - Health economic properties of palbociclib in breast cancer patients with high risk of relapse following neoadjuvant therapy: Results from the Penelope-B trial
Presenter: Katya Galactionova
Session: ePoster Display
133P - Magnetic resonance imaging radiomics predicts high and low recurrence risk and is associated with LncRNAs in early-stage invasive breast cancer
Presenter: Wei Ren
Session: ePoster Display
134P - Enrolment in clinical trials (CT) among patients (pts) with early breast cancer (BC)
Presenter: Daniele Presti
Session: ePoster Display
135P - Hot flashes during adjuvant hormone therapy predict treatment discontinuation and outcome among breast cancer patients
Presenter: Erwei Zeng
Session: ePoster Display
136P - Assessment of sentinel lymph node biopsy versus axillary lymph node dissection on long-term survival in breast cancer patients with pathologically negative lymph node
Presenter: Shusen Wang
Session: ePoster Display
137P - Trial comparing the safety, efficacy and immunogenicity of trastuzumab biosimilar candidate (TX05) with originator trastuzumab in HER2+ early breast cancer
Presenter: Peter Krivorotko
Session: ePoster Display
139P - HER2+/HR+ breast cancer patients at high risk of relapse derive benefit from extended adjuvant treatment with neratinib: An exploratory analysis from ExteNET study
Presenter: Francesco Cognetti
Session: ePoster Display
140P - Benefit of adjuvant chemotherapy in luminal A-like early breast cancer in women aged 40 years or younger: Results of a national multi-institutional study
Presenter: Ondine Dufour
Session: ePoster Display